Skip to main content

Advertisement

SpringerLink
Log in

Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Dementia is a very rare neurological manifestation of systemic lupus erythematosus (SLE) and has a deep link with antiphospholipid antibodies (APL) and cerebral infarction in its development. However, nonvascular dementia irrelevant to APL or cerebral infarction has not been reported in patients with SLE until now. We describe a case of reversible dementia in an SLE patient without APL or cerebral infarction which was successfully treated with corticosteroid and cyclophosphamide. There are two significant points in this case. One is that humoral factors other than APL might be involved in the development of dementia. Secondly, reversible dementia without APL or cerebral infarction may respond more favorably to immunosuppressive therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. [No authors listed] (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599–608

    Article  PubMed  Google Scholar 

  2. West SG (1996) Lupus and central nervous system. Curr Opin Rheumatol 8:408–414

    CAS  PubMed  Google Scholar 

  3. Baca V, Lavalle C, Garcia R, Catalan T, Sauceda JM, Sanchez G, Martinez I, Ramirez ML, Marquez LM, Rojas JC (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 26:432–439

    CAS  PubMed  Google Scholar 

  4. Mok CC, Lau CS, Wong RW (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766–771

    CAS  PubMed  Google Scholar 

  5. Cummings JL, Benson DF (1992) Dementia: a clinical approach. 2nd edn. Butterworth-Heinemann, Boston

  6. Asherson RA, Mercey D, Phillips G, Sheehan N, Gharavi AE, Harris EN, Hughes GR (1987) Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 46:605–611

    CAS  PubMed  Google Scholar 

  7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    PubMed  Google Scholar 

  8. Folstein MF, Folstein SE, McHugh PR (1975) ‘Minimental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    CAS  PubMed  Google Scholar 

  9. Crookes TG (1974) Indices of early dementia on WAIS. Psychol Rep 34:734

    CAS  PubMed  Google Scholar 

  10. Kirk A, Kertesz A, Polk MJ (1991) Dementia with leukoencephalopathy in systemic lupus erythematosus. Can J Neurol Sci 18:344–348

    CAS  PubMed  Google Scholar 

  11. Levine SR, Welch KMA (1987) The spectrum of neurologic disease associated with antiphospholipid antibodies: lupus anticoagulants and anticardiolipin antibodies. Arch Neurol 44:876–883

    CAS  PubMed  Google Scholar 

  12. Coull BM, Bourdette DN, Goodnight SH Jr, Briley DP, Hart R (1987) Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 18:1107–1112

    CAS  PubMed  Google Scholar 

  13. Gorman DG, Cumminges JL (1993) Neurobehavioral presentations of the antiphospholipid antibody syndrome. J Neuropsychiatry Clin Neurosci 5:37–42

    CAS  PubMed  Google Scholar 

  14. Greaves M (1999) Antiphospholipid antibodies and thrombosis. Lancet 353:1348–1353

    CAS  PubMed  Google Scholar 

  15. Ferro D, Basili S, Roccaforte S, Di Franco M, Cipollone F, Ciabattoni G, Davi G (1999) Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. Arthritis Rheum 42:2689–2697

    Article  CAS  PubMed  Google Scholar 

  16. Hactrinski VC, Lassen MA, Marshall J (1974) Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 2:207–210

    Article  PubMed  Google Scholar 

  17. Lojkowska W, Ryglewicz D, Jedrzejczak T, Sienkiewicz-Jarosz H, Minc S, Jakubowska T, Kozlowicz-Gudzinska I (2002) SPECT as a diagnostic test in the investigation of dementia. J Neurol Sci 203-204:215–219

    Google Scholar 

  18. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260

    CAS  PubMed  Google Scholar 

  19. Van Horn G, Arnett FC, Dimachkie MM (1996) Reversible dementia and chorea in a young woman with the lupus anticoagulant. Neurology 46:1599–1603

    PubMed  Google Scholar 

  20. Lai NS, Lan JL (2000) Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 9:353–357

    CAS  PubMed  Google Scholar 

  21. Isshi K, Hirohata S (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 41:1819–1827

    Article  CAS  PubMed  Google Scholar 

  22. Denburg JA, Behmann SA (1994) Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kD reactivity. Ann Rheum Dis 53:304–308

    CAS  PubMed  Google Scholar 

  23. Hanly JG, Hong C, Smith S, Fisk JD (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42:728–734

    Article  CAS  PubMed  Google Scholar 

  24. Kovacs JA, Urowitz MB, Gladman DD (1993) Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am 19:795–814

    CAS  PubMed  Google Scholar 

  25. Hermosillo-Romo D, Brey RL (2002) Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract Res Clin Rheumatol 16:229–244

    Article  PubMed  Google Scholar 

  26. Navarrete MG, Brey RL (2000) Neuropsychiatric systemic lupus erythematosus. Curr Treat Options Neurol 2:473–485

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, Chonbuk, Korea

    S. I. Lee, H. S. Jeon & W. H. Yoo

  2. Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine, #634–18 Keumam Dong, Dukjin Gu, Chonju, Chonbuk 561–712, Korea

    W. H. Yoo

Authors
  1. S. I. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. S. Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. H. Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. H. Yoo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, S.I., Jeon, H.S. & Yoo, W.H. Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction. Rheumatol Int 24, 305–308 (2004). https://doi.org/10.1007/s00296-003-0405-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-003-0405-1

Keywords

Search

Navigation